GlassScriptPhysician profile
Marlene A Azar
NPI 1053816637
$5,323.45
in general payments reported to CMS, 2019-2025
19 companies · $3,455 in 2025
The $3,455 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.47 · 2021: $23.01 · 2022: $369 · 2023: $563 · 2024: $818 · 2025: $3,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $1,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $1,835.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haag-Streit USA, INC. | $3,000.00 | 2025 | |
| Alcon Vision LLC | $786.49 | 2022-2025 | Clareon, Hydrus Microstent, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $315.02 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $245.55 | 2023-2025 | Cequa |
| Glaukos Corporation | $158.88 | 2024 | |
| Bausch & Lomb Americas INC. | $146.04 | 2023-2024 | Miebo, Xiidra |
| Harrow Eye, LLC | $108.50 | 2024-2025 | Vevye |
| Horizon Therapeutics Plc | $105.36 | 2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $96.27 | 2024 | Tecnis Iol |
| Merz North America, INC. | $95.47 | 2020 | |
| Abbvie INC. | $83.95 | 2023-2024 | Alphagan P, Vuity, Lumigan |
| Biotissue Holdings INC. | $39.02 | 2024 | |
| Sight Sciences, INC. | $28.76 | 2024 | Omni Surgical System |
| Allergan, INC. | $23.01 | 2021 | |
| Ocular Therapeutix, INC. | $21.04 | 2025 | Dextenza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $19.74 | 2024 | Ryzumvi, Tyrvaya |
| Apellis Pharmaceuticals, INC. | $18.66 | 2023 | Syfovre |
| Eyevance Pharmaceuticals LLC | $15.98 | 2023 | Flarex |
| Rxsight INC | $15.71 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Azar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.